Kenneth Galbraith, Zymeworks CEO
Zymeworks adds a classic poison pill defense to the armory as the biotech's board battles hostile takeover
Zymeworks $ZYME is pulling out all the stops as it looks to wriggle out of a hostile takeover effort.
A few days ago, Zymeworks CEO …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
